Unknown

Dataset Information

0

Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats.


ABSTRACT: The causative agent of severe acute respiratory syndrome (SARS) has been identified as SARS-associated coronavirus (SARS-CoV), but the prophylactic treatment of SARS-CoV is still under investigation. We constructed a recombinant adenovirus containing a truncated N-terminal fragment of the SARS-CoV Spike (S) gene (from--45 to 1469, designated Ad-S(N)), which encoded a truncated S protein (490 amino-acid residues, a part of 672 amino-acid S1 subunit), and investigated whether this construct could induce effective immunity against SARS-CoV in Wistar rats. Rats were immunized either subcutaneously or intranasally with Ad-S(N) once a week for three consecutive weeks. Our results showed that all of the immunized animals generated humoral immunity against the SARS-CoV spike protein, and the sera of immunized rats showed strong capable of protecting from SARS-CoV infection in vitro. Histopathological examination did not find evident side effects in the immunized animals. These results indicate that an adenoviral-based vaccine carrying an N-terminal fragment of the Spike gene is able to elicit strong SARS-CoV-specific humoral immune responses in rats, and may be useful for the development of a protective vaccine against SARS-CoV infection.

SUBMITTER: Liu RY 

PROVIDER: S-EPMC7114075 | biostudies-literature | 2005 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats.

Liu Ran-Yi RY   Wu Li-Zhi LZ   Huang Bi-Jun BJ   Huang Jia-Ling JL   Zhang Yan-Ling YL   Ke Miao-La ML   Wang Jun-Mei JM   Tan Wei-Ping WP   Zhang Ru-Hua RH   Chen Han-Kui HK   Zeng Yi-Xin YX   Huang Wenlin W  

Virus research 20050901 1-2


The causative agent of severe acute respiratory syndrome (SARS) has been identified as SARS-associated coronavirus (SARS-CoV), but the prophylactic treatment of SARS-CoV is still under investigation. We constructed a recombinant adenovirus containing a truncated N-terminal fragment of the SARS-CoV Spike (S) gene (from--45 to 1469, designated Ad-S(N)), which encoded a truncated S protein (490 amino-acid residues, a part of 672 amino-acid S1 subunit), and investigated whether this construct could  ...[more]

Similar Datasets

| S-EPMC10269910 | biostudies-literature
| S-EPMC8661980 | biostudies-literature
| S-EPMC7484573 | biostudies-literature
| S-EPMC8279943 | biostudies-literature
| S-EPMC8402341 | biostudies-literature
| S-EPMC8312057 | biostudies-literature
| S-EPMC10653869 | biostudies-literature
| S-EPMC10055053 | biostudies-literature
| S-EPMC8396564 | biostudies-literature
| S-EPMC8347908 | biostudies-literature